The Kenya Medical Research Institute Bill, 2025

29 May 2025 domainNational Assembly National Assembly Bills No. 20 of 2025 Gazette: Supplement No. 72
View original PDF

Status Timeline

Proposed

Active now

Public Review

Pending

Debate

Pending

Executive

Pending

Final

Pending

1

KSh 3 Million Fine for Deceptive Traditional Medicine Claims

Clause 46 establishes new criminal offenses related to traditional medicinal products. A person commits an offense and faces a fine of up to KSh 3 million, imprisonment for up to three years, or both, for:

  • Knowingly adding conventional medicines or unauthorized substances to traditional products.
  • Making false, misleading, or deceptive claims about ingredients, benefits, or risks in advertisements.
  • Manufacturing, preparing, or selling products under unsanitary or poor-quality conditions.
2

Written Approval Required to Import or Export Biological Materials

Clauses 54 and 55 introduce a strict licensing and regulatory framework for biobanks and biological materials:

  • Exporting or importing biological materials without prior written approval from the Institute is prohibited.
  • Contravention carries a fine of up to KSh 2 million, imprisonment for up to five years, or both.
  • Unlicensed possession of biological materials carries a similar penalty of up to KSh 2 million or imprisonment up to five years.
3

New Scientific and Ethics Review Unit to Vet Research Proposals

Clause 31 establishes the Scientific and Ethics Review Unit within the Institute. This unit is mandated to:

  • Develop and implement scientific and ethical standards.
  • Review and approve all research proposals to ensure adherence to ethical principles.
  • Monitor ongoing research protocols to ensure compliance.
4

KSh 5 Million General Penalty for Contravention of the Act

Clause 83 establishes a heavy general penalty of up to KSh 5 million, imprisonment for up to three years, or both, for any person who contravenes any provision of the Act where no specific penalty is provided.

Comments (0)

No comments yet. Be the first to start the discussion!